Skip links

QuarkBio’s pioneering product – MIRA™ endometrial receptivity analysis has successfully helped a mother overcome 9 miscarriages

Shin Kong Memorial Hospital, Quark Biosciences, Inc. and GGA Corp. jointly announced a successful clinical case in reproductive medicine. A woman who suffered 9 unsuccessful IVF cycles in the span of 5 years is now healthily pregnant after using the MIRA™ endometrial receptivity analysis to find the optimal window of implantation for her personalized IVF treatment cycle.

For more information:

Close Bitnami banner